Effector Function Characteristics of Exhausted CD8+ T-cell in Microsatellite Stable and Unstable Gastric Cancer
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose Gastric cancer exhibits molecular heterogeneity, with the microsatellite instability–high (MSI-H) subtype drawing attention for its distinct features. Despite a higher survival rate, MSI-H gastric cancer lack significant benefits from conventional chemotherapy. The immune checkpoint inhibitors, presents a potential avenue, but a deeper understanding of the tumor immune microenvironment of MSI-H gastric cancer is essential. Materials and Methods We explored the molecular characteristics of CD8+ T-cell subtypes in three MSI-H and three microsatellite stable (MSS) gastric cancer samples using single-cell RNA sequencing and spatial transcriptome analysis. Results In MSI-H gastric cancer, significantly higher proportions of effector memory T cell (Tem), exhausted T cell (Tex), proliferative exhausted T cell (pTex), and proliferative T cell were observed, while MSS gastric cancer exhibited significantly higher proportions of mucosal-associated invariant T cell and natural killer T cell. In MSI-H gastric cancer, Tex and pTex exhibited a significant upregulation of the exhaustion marker LAG3, as well as elevated expression of effector function markers such as IFNG, GZMB, GZMH, and GZMK, compared to those in MSS gastric cancer. The interferon γ (IFN-γ) signaling pathway of Tex and pTex was retained compared to those of MSS gastric cancer. The spatial transcriptome analysis demonstrates the IFN-γ signaling pathway between neighboring Tex and malignant cell, showcasing a significantly elevated interaction in MSI-H gastric cancer. Conclusion Our study reveals novel finding indicating that IFN-γ signaling pathway is retained in Tex and pTex of MSI-H gastric cancer, offering a comprehensive perspective for future investigations into immunotherapy for gastric cancer.
Abstract
Purpose Gastric cancer exhibits molecular heterogeneity, with the microsatellite instability–high (MSI-H) subtype drawing attention for its distinct features. Despite a higher survival rate, MSI-H gastric cancer lack significant benefits from conventional chemotherapy. The immune checkpoint inhibitors, presents a potential avenue, but a deeper understanding of the tumor immune microenvironment of MSI-H gastric cancer is essential. Materials and Methods We explored the molecular characteristics of CD8+ T-cell subtypes in three MSI-H and three microsatellite stable (MSS) gastric cancer samples using single-cell RNA sequencing and spatial transcriptome analysis. Results In MSI-H gastric cancer, significantly higher proportions of effector memory T cell (Tem), exhausted T cell (Tex), proliferative exhausted T cell (pTex), and proliferative T cell were observed, while MSS gastric cancer exhibited significantly higher proportions of mucosal-associated invariant T cell and natural killer T cell. In MSI-H gastric cancer, Tex and pTex exhibited a significant upregulation of the exhaustion marker LAG3, as well as elevated expression of effector function markers such as IFNG, GZMB, GZMH, and GZMK, compared to those in MSS gastric cancer. The interferon γ (IFN-γ) signaling pathway of Tex and pTex was retained compared to those of MSS gastric cancer. The spatial transcriptome analysis demonstrates the IFN-γ signaling pathway between neighboring Tex and malignant cell, showcasing a significantly elevated interaction in MSI-H gastric cancer. Conclusion Our study reveals novel finding indicating that IFN-γ signaling pathway is retained in Tex and pTex of MSI-H gastric cancer, offering a comprehensive perspective for future investigations into immunotherapy for gastric cancer.
참고문헌 (26)
- Sung H, "Global cancer statistics 2020 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J Clin, 71, pp.209~249 (2021)
- Wadhwa R, "Gastric cancer-molecular and clinical dimensions", Nat Rev Clin Oncol, 10, pp.643~655 (2013)
- Cancer Genome Atlas Research Network, "Comprehensive molecular characterization of gastric adenocarcinoma", Nature, 513, pp.202~209 (2014)
- Pietrantonio F, "Individual patient data meta-analysis of the value of microsatellite instability as a biomarker in gastric cancer", J Clin Oncol, 37, pp.3392~3400 (2019)
- Choi YY, "Microsatellite instability and programmed cell death-ligand 1 expression in stage II", III gastric cancer : post hoc analysis of the CLASSIC randomized controlled study, 2019, pp.270, 309~316
- Liu Y, "Comparative molecular analysis of gastrointestinal adenocarcinomas", Cancer Cell, 33, pp.721~735 (2018)
- Kono K, "Current status of immune checkpoint inhibitors for gastric cancer", Gastric Cancer, 23, pp.565~578 (2020)
- Janjigian YY, "First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma(CheckMate 649) : a randomised, open-label, phase 3 trial", Lancet, 398, pp.27~40 (2021)
- Shitara K, "Efficacy and safety of pembrolizumab or pembrolizumab plus chemotherapy vs chemotherapy alone for patients with first-line, advanced gastric cancer : The KEYNOTE-062 phase 3 randomized clinical trial", JAMA Oncol, 6, pp.1571~1580 (2020)
- Kim ST, "Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer", Nat Med, 24, pp.1449~1458 (2018)
- Li Y, "Single-cell landscape reveals active cell subtypes and their interaction in the tumor microenvironment of gastric cancer", Theranostics, 12, pp.3818~3833 (2022)
- Chen J, "Single-cell profiling of tumor immune microenvironment reveals immune irresponsiveness in gastric signet-ring cell carcinoma", Gastroenterology, 165, pp.88~103 (2023)
- Ahn S, "Applicability of spatial technology in cancer research", Cancer Res Treat, 56, pp.343~356 (2024)
- Lee HS, "Molecular testing for gastrointestinal cancer", J Pathol Transl Med, 51, pp.103~121 (2017)
- Browaeys R, "NicheNet : modeling intercellular communication by linking ligands to target genes", Nat Methods, 17, pp.159~162 (2020)
- Jin S, "Inference and analysis of cell-cell communication using CellChat", Nat Commun, 12, pp.1088~ (2021)
- Newman AM, "Determining cell type abundance and expression from bulk tissues with digital cytometry", Nat Biotechnol, 37, pp.773~782 (2019)
- Cristescu R, "Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes", Nat Med, 21, pp.449~456 (2015)
- Fuchs CS, "Safety and efficacy of pembrolizumab monotherapy in patients with previously treated advanced gastric and gastroesophageal junction cancer : phase 2 clinical KEYNOTE-059 trial", JAMA Oncol, 4, pp.e180013~ (2018)
- Verdegaal EM, "Neoantigen landscape dynamics during human melanoma-T cell interactions", Nature, 536, pp.91~95 (2016)
- Cheng D, "Proliferative exhausted CD8(+)T cells exacerbate long-lasting anti-tumor effects in human papillomavirus-positive head and neck squamous cell carcinoma", Elife, 12, pp.e82705~ (2023)
- Mendoza JL, "Structure of the IFNgamma receptor complex guides design of biased agonists", Nature, 567, pp.56~60 (2019)
- Tau GZ, "Regulation of IFN-gamma signaling is essential for the cytotoxic activity of CD8(+)T cells", J Immunol, 167, pp.5574~5582 (2001)
- Mojic M, "The dark side of IFN-gamma : its role in promoting cancer immunoevasion", Int J Mol Sci, 19, pp.89~ (2017)
- Patel SJ, "Identification of essential genes for cancer immunotherapy", Nature, 548, pp.537~542 (2017)
- Li J, "Remodeling of the immune and stromal cell compartment by PD-1 blockade in mismatch repair-deficient colorectal cancer", Cancer Cell, 41, pp.1152~1169 (2023)